[1] |
ZHANG Mingkang, MA Yanrong, JIN Yongwen, ZHOU Yan, CUI Ruirui, WU Xin'an.
Advances in clinical research on drug-induced acute interstitial nephritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 419-428.
|
[2] |
ZHANG Zhaowei, LI Zuojun, HUANG Jian, LI Shuangqing, HE YiLin.
Exploring the outbreak point for clinical pharmacists to provide pharmaceutical care in nephrology department
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 184-188.
|
[3] |
ZHU Xinru, HUANG Xin.
Roles of indoxyl sulfate in complications of chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 672-679.
|
[4] |
ZHANG Cheng, FAN Manli, WANG Kun, QIN Zhiqiang, ZHOU Lanlan.
Protective effect of dexamethasone implant on nephrotoxicity of adriamycin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 610-617.
|
[5] |
YANG Yanlang, LI Yan, WANG Lin.
Distribution and drug resistance of bacterial pathogens in the infecting inpatients of department of nephrology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 203-208.
|
[6] |
CAI Yipeng, CHEN Quanjin, XIE Peihua, SONG Hongtao.
Effects of Wuzhi capsules on the blood concentration and safety of tarcrolimus compared with diltiazem
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 910-915.
|
[7] |
CHEN Chaohu, ZHUANG Hua, YAO Zhiqiang, HAN Dali, CHANG Cheng, MA Zhongyi, KONG Xiangbing, CAO Jinlong, LI Pan, TIAN Junqiang.
Sodium calcium exchanger and renal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 355-360.
|
[8] |
FANG Xi, QU Qiang, XIAO Xiangcheng.
Advances in the treatment of tacrolimus in idiopathic membranous nephropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 228-234.
|
[9] |
CAI Mingmin,YAO Lan,ZHANG Jingwei,ZHOU Fang,WANG Guangji.
Research progress in drug-induced acute kidney injury based on mitochondrial damage
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 578-585.
|
[10] |
ZHANG Jun, XIE Yanyun, LI Zhi, TAO Lijian.
Effects of splicing factor SRp40 on the expression of GRα/β mRNA and on glucocorticoid therapy for nephrotic syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 589-593.
|
[11] |
HANG Yongfu, LU Guoyuan, SHEN Lei, GAO Jie, QIAO Qing, LI Ming, SHA Wengang, ZHOU Ling, DING Xiaoliang, XIE Cheng.
Efficacy and safety of leflunomide for IgA nephropathy:A meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 60-67.
|
[12] |
PENG Jian-yun, XU Wei-hai, ZHANG Xiao-ru, LAN Le-jian, GUI Zhi-hong, XIANG Mei-juan.
Small dose of tacrolimus combined with hormone in the treatment of refractory nephrotic syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 196-199.
|
[13] |
ZHANG Jin-bo, ZHANG Xiao-le, XU Guo-bin, DONG Zhi-bing, LI Chuan-guang, WANG Wen-long.
Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury following adult cardiothoracic surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1305-1309.
|
[14] |
HUANG Yun-jian, WANG Zi-hua, ZHANG Jing-bo, CHEN Feng, ZHAO Jing-hong.
Therapeutic effects of mycophenolate mofetil in refractory nephrotic syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 186-190.
|
[15] |
LIU Hong, lIU Bi-Cheng.
Significance of urinary measurement of cytokines in diagnosis and treatment of renal diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 366-369.
|